註冊並分享邀請連結,可獲得影片播放與邀請獎勵。

Robert Kruse, MD, PhD
@RobertLKruse
Physician Scientist @UTMB, Biotech Entrepreneur, Clinical training at Harvard, Johns Hopkins; Yale alumnus, Opinions are my own, do not represent medical advise
加入 April 2015
982 正在關注    3.2K 粉絲
One of the biggest challenges I see for Claude and AI in biotech drug development is that LLMs are based on published data, patents, etc. But when industry (and my company) try to replicate published work, the failure rate is at least 50-65%. How does the AI know what to trust?
顯示更多
0
29
236
40
轉發到社區